Xenon Pharmaceuticals Inc.
NASDAQ: XENE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Andrea DiFabio
- Employees
- 316
- Headquarters
- Burnaby, Canada
- IPO year
- 2014
- Market cap
- $4.2B
- Website
- https://www.xenon-pharma.com
Loading XENE…
Loading profile data…Frequently asked questions about XENE
What does Xenon Pharmaceuticals Inc. (XENE) do?
Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and advancing innovative treatments for individuals living with neurological disorders. The company operates primarily from its headquarters in Burnaby, Canada. Its robust clinical pipeline showcases several promising candidates: XEN496, an activato...
Where does XENE trade?
Xenon Pharmaceuticals Inc. (XENE) trades on the NASDAQ Global Market.
What sector is XENE in?
Xenon Pharmaceuticals Inc. (XENE) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Xenon Pharmaceuticals Inc.?
Andrea DiFabio is the chief executive officer of Xenon Pharmaceuticals Inc. (XENE).
Where is Xenon Pharmaceuticals Inc. headquartered?
Xenon Pharmaceuticals Inc. is headquartered in Canada.
Does XENE pay a dividend?
Xenon Pharmaceuticals Inc. (XENE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did XENE go public?
Xenon Pharmaceuticals Inc. (XENE) completed its initial public offering in 2014.